Strategy and Planning

Alava participates in the business of biopharm as well as CMC activities. Our team has experience with venture capital financing, board membership, and CEO/COO responsibilities. For investors, M&A assessment and in-licensing, Alava can help assess technical and CMC-regulatory risk, development plans, and team capabilities. For product developers, we can help prepare plans, budgets and diligence materials, and address topics that could endanger a deal.